Treating metastatic melanoma with Stereotactic Ablative Body Radiotherapy and IMmune Pathway ACTivation (SABR-IMPACT)

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/18

Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma
Edwards, J. M., Andrews, M. C., Burridge, H., Smith, R., Owens, C., Edinger, M., Pilkington, K., Desfrancois, J., Shackleton, M., Senthi, S. & van Zelm, M. C., Sept 2023, In: Clinical & Translational Immunology. 12, 9, 16 p., e1466.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

6 Citations (Scopus)
The normal tissue effects of microbeam radiotherapy: What do we know, and what do we need to know to plan a human clinical trial?
Smyth, L. M. L., Senthi, S., Crosbie, J. C. & Rogers, P. A. W., 2 Jun 2016, In: International Journal of Radiation Biology. 92, 6, p. 302-311 10 p.
Research output: Contribution to journal › Review Article › Research › peer-review

43 Citations (Scopus)

Project Details